A vaccine designed to target two different forms of Covid will be offered as part of the autumn booster programme, after the jab was approved by the UK’s regulator.
Manufactured by the US firm Moderna, the jab not only attacks the original coronavirus – as is the case for vaccines currently in use – but is designed specifically for the Omicron variant BA.1, which fuelled a wave of the virus in the UK last winter.
The UK is the first country to approve the bivalent vaccine, known as “Spikevax bivalent Original/Omicron”, giving the green light for its use as a booster for people over the age of 18.
The Joint Committee on Vaccination and Immunisation (JCVI) said the vaccine would be used in the planned autumn booster programme. This is expected to begin in September, in advance of what could be a difficult period for the NHS with an expected surge in respiratory diseases including Covid and flu.
Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said clinical trials had shown the bivalent vaccine provided a strong immune response against the Omicron BA.1 variant and the original 2020 strain.
Diese Geschichte stammt aus der August 16, 2022-Ausgabe von The Guardian.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der August 16, 2022-Ausgabe von The Guardian.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Waking a dormant giant: Marseille are on a mission
Getting to grips with the French club is like 'sitting on a volcano' but they are thinking big and a Europa League semi-final awaits.
'Croke Park is steeped in culture. It means so much'
Leinster prop Porter aims touse recent European pain as fuel for semi-final gain against Northampton
Surrey’s Steel flexes golden arm to thrust himself into limelight
Leg-spinner who isthe top wicket-taker despite early start to Championship has England ambitions
'It's punishing' Non-dom says tax change will force him to leave Britain
Bassim Haidar is house hunting. He owns \"more than 10 properties\" in central including a London, £20m five-bedroom flat near Chelsea's Sloane Square.
Japan's empty homes top 9m as population keeps falling
As the declining population continues to affect Japan's society, the number of vacant houses has topped 9m - enough to accommodate the entire population of Australia at three people per dwelling.
Liberty leads the people - but now showing her true colours
For almost 200 years, she has been the definitive symbol of the French republic. Now, after a much-needed facelift, Eugène Delacroix's Liberty Leading the People will rise above the fray of revolutionary anarchy in her true colours once more.
Netanyahu faces new pressure to let more aid into Gaza as talks on hostages continue
Israel's leaders were under renewed pressure to allow more aid into Gaza yesterday, after the US secretary of state, Antony Blinken, told Benjamin Netanyahu to \"accelerate and sustain improvements\" in the amount of humanitarian assistance reaching the territory.
EU calls for halt to police violence inGeorgia after force used on protesters
Western politicians and diplomats have called for a halt to rising violence in Georgia after security forces used water cannon, tear gas, stun grenades and rubber bullets overnight to break up a peaceful rally against a \"foreign influence\" bill.
Trans rights row with Rowling is really sad’Radcliffe
Daniel Radcliffe has described his rupture with JK Rowling over trans rights as \"really sad\", and said that her role in his life as the creator of Harry Potter \"doesn't mean you owe the things you truly believe to someone else for your entire life\".
Infected blood inquiry: study saying risks were tolerable’ omitted death
A study cited at the infected blood inquiry as evidence that the devastating consequences of blood products contaminated with hepatitis could not have been foreseen misrepresented the results of a trial in making its case, the Guardian can reveal.
